The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Open accessAbstract
As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mucocutaneous and visceral disease can be lethal if untreated, but most deaths are attributable to visceral leishmaniasis (103).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depending on the species, Leishmania can cause self-healing cutaneous lesions (e.g., L. tropica, L. major, L. mexicana, and L. pifanoi), disfiguring mucocutaneous disease (e.g., L. braziliensis and L. guyanensis), or severe visceral illness (e.g., L. donovani and L. Infantum chagasi).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [103]
Experimental — accuracy not yet measuredIn the citing paper
“we must consider the important zoonotic potential of the diseases studied, as the presence of human infections or risk of infection has already been described (5, 24, 25, 28).”
From Current Distribution of Selected Vector-Borne Diseases in Dogs in Spain (2020) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Cited by 6,884
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Leishmaniasis: current situation and new perspectives
Desjeux, P. M. P. (2004) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,329 · cited 1×
“Reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden, but studies that measure the degree of underreporting are rare [23].”
BackgroundBank, W. (1993) · doi:10.1596/0-1952-0890-0 · Cited by 2,213
King, C. H., Dickman, K. R., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 898 · cited 1×
“The accuracy of this measure depends on the reliability of the incidence, duration, severity and mortality data for a given condition, as well as the underlying assumptions used in the calculations [7,14].”
BackgroundHealth metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E. A., Sachs, S. E., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 822 · cited 1×
“Although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities [1,2].”
BackgroundAlvar, J., Yactayo, S., & Bern, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.004 · Cited by 813 · cited 1×
“This consignment to critical oblivion results from its complex epidemiology and ecology, the lack of simple, easily-applied tools for case management and the paucity of current incidence data, and often results in a failure on the part of policy-makers to recognize its importance [3,4].”
BackgroundDesjeux, P. M. P. (1996) · Clinics in Dermatology · doi:10.1016/0738-081x(96)00057-0 · Cited by 588 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
BackgroundLibrary, W. (2010) · Cited by 584
Flagged first, then by citations
Research works printed but not linked: 1
- AN Maia-Elkhoury, 2007, [Analysis of visceral leishmaniasis reports by the capture-recapture method]., Rev Saude Publica, 41, 931
Cited by
Sorted by citations
Items 401–500 of 1,004
Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors
Gurung, P., & Kanneganti, T. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2212-3 · Cited by 68
Kimutai, R., Musa, A. M., Njoroge, S., Omollo, R., Alves, F. P., Hailu, A., Khalil, E. A. G., Diro, E., Soipei, P., Younis, B. M., et al. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-016-0481-0 · Cited by 66
Abbasi, I., Aramin, S., Hailu, A., Shiferaw, W., Kassahun, A., Belay, S., Jaffe, C. L., & Warburg, A. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-153 · Cited by 65
The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis
de Freitas, E. O., Leoratti, F. M. S., Freire-de-Lima, C. G., Morrot, A., & Feijó, D. F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00153 · Cited by 65
Rocha, M. A. N., Rocha, T. J. M., Panjwani, C. M. B. R. G., & Abreu, S. R. O. (2018) · Brazilian Journal of Biology · doi:10.1590/1519-6984.166622 · Cited by 65
Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis
Badirzadeh, A., Heidari‐Kharaji, M., Omrani, V. F., Dabiri, H., Araghi, A., & Chirani, A. S. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007843 · Cited by 65
A review of current treatments strategies based on paromomycin for leishmaniasis
Matos, A. P. D. S., Viçosa, A. L., Ré, M. I., Ricci‐Júnior, E., & Holandino, C. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101664 · Cited by 65
Structure-Based Design of Potent and Selective Leishmania N -Myristoyltransferase Inhibitors
Hutton, J. A., Gonçalves, V., Brannigan, J. A., Paape, D., Wright, M. H., Waugh, T. M., Roberts, S. M., Bell, A., Wilkinson, A. J., Smith, D. F., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5011397 · Cited by 67
NLR proteins and parasitic disease
Clay, G. M., Sutterwala, F. S., & Wilson, M. E. (2014) · Immunologic Research · doi:10.1007/s12026-014-8544-x · Cited by 67
Bibliometric analysis of leishmaniasis research in Medline (1945-2010)
Ramos, J. M., González‐Alcaide, G., & Bolaños-Pizarro, M. (2013) · Parasites & Vectors · doi:10.1186/1756-3305-6-55 · Cited by 65
Ejazi, S. A., & Ali, N. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.148 · Cited by 65
1-Deoxynojirimycin and its Derivatives: A Mini Review of the Literature
Wang, H., Shen, Y., Zhao, L., & Ye, Y. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200114112728 · Cited by 66
Prasanna, P., Kumar, P., Kumar, S., Rajana, V. K., Kant, V., Prasad, S. R., Mohan, U., Ravichandiran, V., & Mandal, D. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111920 · Cited by 67
Parasitic Infections: A Role for C-Type Lectins Receptors
Vázquez-Mendoza, A., Carrero, J. C., & Rodríguez‐Sosa, M. (2013) · BioMed Research International · doi:10.1155/2013/456352 · Cited by 64
Abass, E. M., Bollig, N., Reinhard, K., Camara, B., Mansour, D., Visekruna, A., Lohoff, M. D., & Steinhoff, U. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002322 · Cited by 64
Bacon, K. M., Hotez, P. J., Kruchten, S. D., Kamhawi, S., Bottazzi, M. E., Valenzuela, J. G., & Lee, B. Y. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.032 · Cited by 64
Kaushal, H., Bras‐Gonçalves, R., Negi, N. S., Lemesre, J.-L., Papierok, G., & Salotra, P. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0653-6 · Cited by 64
Wound healing in cutaneous leishmaniasis: A double edged sword of IL-10 and TGF-β
Abdoli, A., Maspi, N., & Ghaffarifar, F. (2017) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2017.02.001 · Cited by 66
Franco, L. H., Fleuri, A. K. A., Pellison, N. C., Quirino, G. F. S., Horta, C. V., de Carvalho, R. A., Oliveira, S. C., & Zamboni, D. S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.780981 · Cited by 62
Grimaldi, G., Têva, A., dos Santos, C. B., Santos, F. N., Pinto, I. D. S., Fux, B., Leite, G. R., & Falqueto, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185438 · Cited by 64
Zhang, C., Bourgeade‐Delmas, S., Álvarez, Á. F., Valentin, A., Hemmert, C., & Gornitzka, H. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.060 · Cited by 64
Sharifi, I., Khosravi, A., Aflatoonian, M. R., Salarkia, E., Bamorovat, M., Karamoozian, A., Nekoei‐Moghadam, M., Sharifi, F., Afshar, A. A., Afshari, S. A. K., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1091709 · Cited by 64
“Leishmaniasis is still the third most vector-borne disease and is frequently fatal if it remains untreated in 101 tropical and subtropical countries and territories (5, 6).”
BackgroundEpidemiology of Imported Leishmaniasis in Italy: Implications for a European Endemic Country
Muccio, T. D., Scalone, A., Bruno, A., Marangi, M., Grande, R., Armignacco, O., Gradoni, L., & GRAMICCIA, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129418 · Cited by 63
An overview on Leishmania vaccines: A narrative review article.
Rezvan, H., & Moafi, M. (2015) · PubMed Central · Cited by 63
Comparative genomic analysis of Leishmania (Viannia) peruviana and Leishmania (Viannia) braziliensis
Valdivia, H. O., Reis-Cunha, J. L., Rodrigues-Luiz, G. F., Baptista, R. P., Baldeviano, G. C., Gerbasi, V. R., Dobson, D. E., Pratlong, F., Bastien, P., Lescano, A. G., et al. (2015) · BMC Genomics · doi:10.1186/s12864-015-1928-z · Cited by 63
Requena, J. M., Montalvo, A. M., & Fraga, J. (2015) · BioMed Research International · doi:10.1155/2015/301326 · Cited by 62
Duncan, S. M., Myburgh, E., Philipon, C. I. M. S., Brown, E. H., Meissner, M., Brewer, J. M., & Mottram, J. C. (2016) · Molecular Microbiology · doi:10.1111/mmi.13375 · Cited by 63
Trinconi, C. T., Reimão, J. Q., Coelho, A. C., & Uliana, S. R. B. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv495 · Cited by 63
Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids
Geiger, A., Bossard, G., Séréno, D., Pissarra, J., Lemesre, J.-L., Vincendeau, P., & Holzmüller, P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00212 · Cited by 65
Dermoscopic findings in different clinical variants of lichen planus. Is dermoscopy useful?
Friedman, P., Sabban, E. C., Marcucci, C., Peralta, R., & Cabo, H. (2015) · Dermatology Practical & Conceptual · doi:10.5826/dpc.0504a13 · Cited by 63
Skin parasite landscape determines host infectiousness in visceral leishmaniasis
Doehl, J. S. P., Bright, Z., Dey, S., Davies, H. L., Magson, J., Brown, N., Romano, A., Dalton, J. E., Pinto, A. I., Pitchford, J. W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00103-8 · Cited by 62
Essential Oil from Piper aduncum: Chemical Analysis, Antimicrobial Assessment, and Literature Review
Monzote, L., Scull, R., Cos, P., & Setzer, W. N. (2017) · Medicines · doi:10.3390/medicines4030049 · Cited by 65
Medicinal components in Termitomyces mushrooms
Hsieh, H., & Ju, Y. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-8991-8 · Cited by 63
Dutari, L. C., & Loaiza, J. R. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-218 · Cited by 62
Dhiman, R. C., & Yadav, R. S. (2016) · Infectious Diseases of Poverty · doi:10.1186/s40249-016-0200-3 · Cited by 64
Olliaro, P., Grögl, M., Boni, M., Carvalho, E. M., Chebli, H., Cissé, M., Diro, E., Cota, G., Erber, A. C., Gadisa, E., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006141 · Cited by 62
Asfaram, S., Fakhar, M., & Teshnizi, S. H. (2019) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/1678-9199-jvatitd-2019-0012 · Cited by 62
Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases
Lanza, J. S., Pomel, S., Loiseau, P. M., & Frézard, F. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1659243 · Cited by 62
Cardona‐Arias, J. A., Vélez, I. D., & López‐Carvajal, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122569 · Cited by 62
Inacio, J. D. F., Gervazoni, L. F. O., Canto‐Cavalheiro, M. M., & de Almeida-Amaral, E. E. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003093 · Cited by 62
Bhattacharyya, T., Boelaert, M., & Miles, M. A. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002057 · Cited by 62
Sweileh, W. M., Zyoud, S. H., Al‐Jabi, S. W., & Sawalha, A. F. (2015) · Archives of Public Health · doi:10.1186/2049-3258-73-1 · Cited by 62
Kumar, N. P., Srinivasan, R., Anish, T. S., Nandakumar, G., & Jambulingam, P. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.076695-0 · Cited by 62
Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets
Vermelho, A. B., Capaci, G. R., Rodrigues, I. A., Cardoso, V. D. S., Mazotto, A. M., & Supuran, C. T. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.01.034 · Cited by 62
Cincurá, C., de Lima, C. M. F., Machado, P. R. L., Filho, J. O., Glesby, M. J., Lessa, M. M., & Carvalho, E. M. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0349 · Cited by 62
Incidence and Trends of Leishmaniasis and Its Risk Factors in Humera, Western Tigray
Tedla, D. G., Hailemariam, F., & Abreha, H. H. (2018) · Journal of Parasitology Research · doi:10.1155/2018/8463097 · Cited by 62
Pountain, A. W., Weidt, S. K., Regnault, C., Bates, P. A., Donachie, A. M., Dickens, N. J., & Barrett, M. P. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007052 · Cited by 62
Patiño, L. H., Imamura, H., Cruz‐Saavedra, L., Pavia, P. X., Muskus, C., Méndez, C., Dujardin, J., & Ramírez, J. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-45538-9 · Cited by 66
Is leishmaniasis the new emerging zoonosis in the world?
Montaner-Angoiti, E., & Llobat, L. (2023) · Veterinary Research Communications · doi:10.1007/s11259-023-10171-5 · Cited by 61
“L. tropica has been reported in Greece, and neighboring countries causing sporadically anthroponotic cutaneous leishmaniasis (Alvar et al. 2012; Antoniou et al. 2013; Ber-riatua et al. 2021; El Idrissi et al. 2022).”
Natural infection of bats with Leishmania in Ethiopia
Kassahun, A., Sádlová, J., Benda, P., Košťálová, T., Warburg, A., Hailu, A., Baneth, G., Volf, P., & Votýpka, J. (2015) · Acta Tropica · doi:10.1016/j.actatropica.2015.07.024 · Cited by 61
Ferreira, C., Soares, D. C., Nascimento, M. T. C., Pinto-da-Silva, L. H., Sarzedas, C. G., Tinoco, L. W., & Saraiva, E. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00093-14 · Cited by 61
Nzelu, C. O., Kato, H., Puplampu, N., Desewu, K., Odoom, S., Wilson, M. D., Sakurai, T., Katakura, K., & Boakye, D. A. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002630 · Cited by 61
Antiprotozoal Activity of Quinonemethide Triterpenes from Maytenus ilicifolia (Celastraceae)
Santos, V. D., Leite, K., Siqueira, M. D. C., Regasini, L. O., Martinez, I., Nogueira, C., Galuppo, M. K., Stolf, B. S., Pereira, A. M. S., Cicarelli, R. M. B., et al. (2013) · Molecules · doi:10.3390/molecules18011053 · Cited by 61
Osorio, E. Y., Travi, B. L., da Cruz, A. M., Saldarriaga, Ó. A., Medina-Colorado, A. A., & Melby, P. C. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004165 · Cited by 61
Lv, M., Zhao, J., Deng, Z., & Yu, Y. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.09.005 · Cited by 61
Tiwari, N. K., Kumar, V., Gedda, M. R., Singh, A. K., Singh, V. K., Singh, S. P., & Singh, R. K. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00314 · Cited by 61
Castro, M. D. M., Cossio, A., Velasco, C., & Osório, L. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005515 · Cited by 61
Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey
Uzun, S., Gürel, M. S., Durdu, M., Akyol, M., Karaman, B. F., Aksoy, M., Aytekin, S., Borlu, M., Doğan, E. İ., Doğramacı, Ç. A., et al. (2018) · International Journal of Dermatology · doi:10.1111/ijd.14002 · Cited by 61
Leishmania vaccine development: exploiting the host–vector–parasite interface
Reed, S. N., Coler, R., Mondal, D., Kamhawi, S., & Valenzuela, J. C. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1105135 · Cited by 60
Retracted:Leishmania infection activates host mTOR for its survival by M2 macrophage polarization
Kumar, A., Das, S., Mandal, A., Verma, S., Abhishek, K., Kumar, A., Kumar, V., Ghosh, A. K., & Das, P. K. (2018) · Parasite Immunology · doi:10.1111/pim.12586 · Cited by 60
RetractedThe Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by Leishmania Infection
Passelli, K., Billion, O., & Tacchini‐Cottier, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649348 · Cited by 60
Iatta, R., Mendoza‐Roldan, J. A., Latrofa, M. S., Cascio, A., Brianti, E., Pombi, M., Gabrielli, S., & Otranto, D. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009817 · Cited by 60
A machine learning-based system for detecting leishmaniasis in microscopic images
Zare, M., Akbarialiabad, H., Parsaei, H., Asgari, Q., Alinejad, A., Bahreini, M. S., Hosseini, S. H., Ghofrani-Jahromi, M., Shahriarirad, R., Amirmoezzi, Y., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07029-7 · Cited by 60
Challapa-Mamani, M. R., Tomás-Alvarado, E., Espinoza-Baigorria, A., León‐Figueroa, D. A., Sah, R., Rodriguez-Morales, A. J., & Barboza, J. J. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8100457 · Cited by 60
Hombach, A., Ommen, G., MacDonald, A., & Clos, J. (2014) · Journal of Cell Science · doi:10.1242/jcs.157297 · Cited by 60
Moreira, O. C., Yadón, Z. E., & Cupolillo, E. (2017) · Acta Tropica · doi:10.1016/j.actatropica.2017.09.020 · Cited by 60
Screening a Natural Product-Based Library against Kinetoplastid Parasites
Zulfiqar, B., Jones, A., Sykes, M. L., Shelper, T., Davis, R. A., & Avery, V. M. (2017) · Molecules · doi:10.3390/molecules22101715 · Cited by 64
Biosynthesized Colloidal Silver and Gold Nanoparticles As Emerging Leishmanicidal Agents: an Insight
Ovais, M., Nadhman, A., Khalil, A. T., Raza, A., Khuda, F., Sohail, M. F., Ullah, N., Islam, N. U., Sarwar, H. S., Shahnaz, G., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0233 · Cited by 60
Current Distribution of Selected Vector-Borne Diseases in Dogs in Spain
Montoya-Alonso, J. A., Morchón, R., Costa-Rodríguez, N., Matos, J. I., Falcón-Cordón, Y., & Carretón, E. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.564429 · Cited by 59
Pareyn, M., Alves, F. P., Burza, S., Chakravarty, J., Alvar, J., Diro, E., Kaye, P. M., & van Griensven, J. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00663-w · Cited by 60
“Skin transcriptomics of patients from Iran and Sri Lanka with cutaneous leishmaniasis indicates activation of multiple immune pathways and gene signatures associated with epidermal remodelling 115,118 .”
InfluentialPeixoto, H. M., de Oliveira, M. R. F., & Romero, G. A. S. (2014) · Tropical Medicine & International Health · doi:10.1111/tmi.12429 · Cited by 63
Bhattacharyya, T., Armon, A., Falconar, A. K. I., Sundar, S., EL-Safi, S. H., Gripenberg, M. A., Bowes, D. E., Thunissen, C., Singh, O. P., Kumar, R., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003273 · Cited by 59
Pereira, A. V., de Barros, G. A. C., Pinto, É. G., Tempone, A. G., Orsi, R. D. O., dos Santos, L. D., Calvi, S. A., Ferreira, R. S., Pimenta, D. C., & Barraviera, B. (2016) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1186/s40409-016-0055-x · Cited by 59
Pablos, L. D., Ferreira, T., & Walrad, P. B. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.08.004 · Cited by 59
Clinical features and treatment response of cutaneous leishmaniasis in North‐West Ethiopia
Fikre, H., Mohammed, R., Atinafu, S., van Griensven, J., & Diro, E. (2017) · Tropical Medicine & International Health · doi:10.1111/tmi.12928 · Cited by 59
Role of Mast Cells in clearance of Leishmania through extracellular trap formation
Naqvi, N., Ahuja, K., Selvapandiyan, A., Dey, R., Nakhasi, H. L., & Puri, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-12753-1 · Cited by 62
Duffin, R. N., Blair, V. L., Kedzierski, Ł., & Andrews, P. C. (2017) · Dalton Transactions · doi:10.1039/c7dt04171c · Cited by 59
Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis
Smith, L. D., Serrano, D. R., Mauger, M., Bolás-Fernández, F., Dea‐Ayuela, M. A., & Lalatsa, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00097 · Cited by 59
Giraud, É., Martín, O., Yakob, L., & Rogers, M. E. (2019) · Communications Biology · doi:10.1038/s42003-019-0323-8 · Cited by 59
Insights into the current status of privileged N-heterocycles as antileishmanial agents
Razzaghi‐Asl, N., Sepehri, S., Ebadi, A., Karami, P., Nejatkhah, N., & Ahar, M. J. (2019) · Molecular Diversity · doi:10.1007/s11030-019-09953-4 · Cited by 59
Global database of leishmaniasis occurrence locations, 1960–2012
Pigott, D. M., Golding, N., Messina, J. P., Battle, K. E., Duda, K. A., Balard, Y., Bastien, P., Pratlong, F., Brownstein, J. S., Freifeld, C. C., et al. (2014) · Scientific Data · doi:10.1038/sdata.2014.36 · Cited by 59
Chowdhury, R., Mondal, D., Chowdhury, V., Faria, S., Alvar, J., Nabi, S. G., Boelaert, M., & Dash, A. P. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003020 · Cited by 58
Ehrenberg, J. P., Zhou, X.-N., Fontes, G., da Rocha, E. M. M., Tanner, M., & Utzinger, J. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00701-7 · Cited by 58
Ostyn, B., Uranw, S. K., Bhattarai, N. R., Das, M. L., Rai, K., Tersago, K., Pokhrel, Y., Durnez, L., Marasini, B., der Auwera, G. V., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003966 · Cited by 58
Exposure to Leishmania spp. and sand flies in domestic animals in northwestern Ethiopia
Rohoušová, I., Talmi-Frank, D., Košťálová, T., Polanská, N., Leštinová, T., Kassahun, A., Yasur-Landau, D., Maia, C., King, R., Votýpka, J., et al. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0976-1 · Cited by 58
Therapeutic vaccines for leishmaniasis
Khamesipour, A. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.945415 · Cited by 58
Singh, O. P., Stober, C. B., Singh, A. K., Blackwell, J. M., & Sundar, S. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001874 · Cited by 58
Developments in Diagnosis and Antileishmanial Drugs
Bhargava, P., & Singh, R. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/626838 · Cited by 58
Tegumentary leishmaniasis in the State of Amazonas: what have we learned and what do we need?
Guerra, J. A. D. O., Maciel, M. G., Guerra, M. V. D. F., Talhari, A. C., Prestes, S. R., Fernandes, M. A., Da‐Cruz, A. M., da Fonseca-Martins, A. M., Coelho, L. I. D. A. R. C., Romero, G. A. S., et al. (2015) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0268-2013 · Cited by 58
Duarte, M. C., Lage, D. P., Martins, V. T., Chávez‐Fumagalli, M. Á., Roatt, B. M., Menezes‐Souza, D., Goulart, L. R., Soto, M., Tavares, C. A. P., & Coelho, E. A. F. (2016) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0120-2016 · Cited by 58
Rutte, E. A. L., Chapman, L. A. C., Coffeng, L. E., Jervis, S., Hasker, E. C., Dwivedi, S., Karthick, M., Das, A., Mahapatra, T., Chaudhuri, I., et al. (2017) · Epidemics · doi:10.1016/j.epidem.2017.01.002 · Cited by 58
Villa-Pulgarín, J. A., Gajate, C., Botet, J., Jiménez, A., Justies, N., Varela-M, R. E., Cuesta-Marbán, Á., Müller, I., Modolell, M., Revuelta, J. L., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005805 · Cited by 58
Guimarães-e-Silva, A. S., Silva, S. D. O., da Silva, R. C. R., Pinheiro, V. C. S., Rebêlo, J. M. M., & Melo, M. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179052 · Cited by 58
von Stebut, E., & Tenzer, S. (2017) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.11.002 · Cited by 58
Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis
Kumar, R., Chauhan, S. B., Ng, S. S., Sundar, S., & Engwerda, C. R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01492 · Cited by 58
Garcia, A. R., de Oliveira, D. M. P., Amaral, A. C. F., de Jesus, J. B., Sodero, A. C. R., de Souza, A. M. T., Supuran, C. T., Vermelho, A. B., Rodrigues, I. A., & Pinheiro, A. S. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1616182 · Cited by 58
Chaves, M. M., Sinflorio, D. A., Thorstenberg, M. L., Martins, M. D. A., Moreira-Souza, A. C. A., Rangel, T. P., Silva, C. L. M., Bellio, M., Canetti, C. D. A., & Coutinho‐Silva, R. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007887 · Cited by 60
Regulation of Translation in the Protozoan Parasite Leishmania
Karamysheva, Z., Guarnizo, S. G. G., & Karamyshev, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082981 · Cited by 45
Natural products in antiparasitic drug discovery: advances, opportunities and challenges
Shang, X., Dai, L., Cao, X., Ma, Y., Gulnaz, I., Miao, X., Li, X., & Yang, X. (2025) · Natural Product Reports · doi:10.1039/d5np00007f · Cited by 57
Stauch, A., Duerr, H.-P., Dujardin, J., Vanaerschot, M., Sundar, S., & Eichner, M. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001973 · Cited by 57
Metadata
- Authors
- Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team
- Affiliations
- World Health Organization (CH)
- Universidad de Antioquia (CO)
- Centers for Disease Control and Prevention (US)
- Instituto de Salud Carlos III (ES)
- Corresponding author
- Alvar, Jorge
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-31
- Volume
- 7
- Issue
- 5
- Pages
- e35671
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3365071
- OpenAlex
- W2107915297
- Cited by
- 5,141
- References
- 51
- Citations by year
- 2026: 177 · 2025: 229 · 2024: 257 · 2023: 305 · 2022: 358 · 2021: 456 · 2020: 468 · 2019: 458 · 2018: 515 · 2017: 440 · 2016: 465 · 2015: 361 · 2014: 404 · 2013: 200 · 2012: 38
- FWCI
- 310.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Sanofi
- Universidad de Medellín
- Pan American Health Organization
- Agencia Española de Cooperación Internacional para el Desarrollo
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › Brucella: diagnosis, epidemiology, treatment
- Keywords
- leishmaniasis, visceral leishmaniasis, cutaneous leishmaniasis, leishmaniasis incidence, country profile, leishmaniasis control, leishmaniasis treatment, access to medicines, neglected tropical diseases, case data
- MeSH terms
- Female, Geography, Humans, Leishmaniasis, Male, Time Factors, World Health Organization, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
